MRNA Congressional Trades
7 trades by 1 members of Congress (May 2020 – Feb 2024)
Last updated March 21, 2026
Congress members who trade MRNA
Recent MRNA trades
| Date | Politician | Action | Amount | Alpha |
|---|---|---|---|---|
| 2024-02-01 | Josh Gottheimer | SELL | $1K-$15K | — |
| 2023-09-15 | Josh Gottheimer | SELL | $1K-$15K | — |
| 2023-03-31 | Josh Gottheimer | BUY | $1K-$15K | -27.24% |
| 2022-03-16 | Josh Gottheimer | SELL | $1K-$15K | — |
| 2021-07-22 | Josh Gottheimer | SELL | $1K-$15K | — |
| 2021-03-15 | Josh Gottheimer | SELL | $1K-$15K | — |
| 2020-05-22 | Josh Gottheimer | SELL | $1K-$15K | — |
Frequently Asked Questions
Which Congress members trade MRNA?
1 members of Congress have traded MRNA. Top traders include: Josh Gottheimer. See the full list below.
Is Congress buying or selling MRNA?
Congress has made 1 purchases and 6 sales of MRNA. The buy/sell ratio is 0.2x.
Do Congress MRNA trades beat the market?
Congressional trades in MRNA have a 0% win rate against the S&P 500, with an average alpha of -27.2%.
How is alpha calculated?
Alpha measures how much a trade outperformed the S&P 500 over the same holding period. For each politician, we show their dollar-weighted alpha—larger positions count more. A politician with +404% alpha on NVDA means their NVDA trades, weighted by size, beat the market by 404 percentage points.
What does the win rate mean?
Win rate is the percentage of trades that beat the S&P 500. Note that win rate treats all trades equally—a $5K trade counts the same as a $5M trade. This is why some traders show high alpha but moderate win rates (big wins, small losses) or low alpha but high win rates (consistent small wins).